Cipla Quality Chemical Industries plans to enter IPO market

Cipla said," Certain shareholders may consider selling down part or all of their stake to enable sufficient free float and liquidity.The Cipla group intends to continue holding the majority of stake and control in the subsidiary."

Cipla Quality Chemical Industries plans to enter IPO market
For this IPO, Kenya-based Renaissance Capital Limited has been appointed as the official book runner. Photo: Official Website

Drug-maker Cipla on Friday announced that it's subsidiary Cipla Quality Chemical Industries (CiplaQCIL) has evaluated an initial public offering (IPO) as a part of growth strategy. 

Cipla said," Certain shareholders may consider selling down part or all of their stake to enable sufficient free float and liquidity.The Cipla group intends to continue holding the majority of stake and control in the subsidiary."

For this IPO, Kenya-based Renaissance Capital Limited has been appointed as the official book runner. 

The transation would be subject to approval of the relevant market regulators. 

This fiscal year the IPO market is on the booming level, so far 19 companies have entered the stock exchanges via this portal. 

Shares of Cipla on BSE, was trading at Rs at Rs 558.70 down by Rs 5.55 or 0.98%.  

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

Written By: ZeeBiz WebTeam
Updated: Fri, Nov 11, 2016
10:51 am
Mumbai, ZeeBiz WebDesk
RELATED NEWS
Cipla Q3 Results: Net profit rises 10% but fails to keep up with analysts' estimates Cipla Q3 Results: Net profit rises 10% but fails to keep up with analysts' estimates
Tata Motors, Bajaj Auto, Dr Reddy’s Laboratories, and Cipla are in focus ahead of Q3 results today Tata Motors, Bajaj Auto, Dr Reddy’s Laboratories, and Cipla are in focus ahead of Q3 results today
After Sensex, Nifty's Santa rally today, these banks and pharma stocks may give returns up to 7-25% - what should investors do? After Sensex, Nifty's Santa rally today, these banks and pharma stocks may give returns up to 7-25% - what should investors do?